Comparing Cold Sore Treatment Options Available
Aciclovir 400mg Tablets: Primary Oral Treatment
Aciclovir 400mg tablets represent the most commonly prescribed oral antiviral treatment for cold sores in the UK. This medication works by interfering with viral DNA replication, potentially reducing outbreak duration from 7-10 days to approximately 4-6 days when treatment begins early. The typical dosing regimen involves taking 400mg three times daily for five days, though some patients may require longer courses depending on symptom severity.
Alternative Oral Antiviral Options
Valaciclovir 500mg tablets offer an alternative approach with the convenience of twice-daily dosing compared to aciclovir's three-times-daily schedule. This medication converts to aciclovir in the body but may achieve higher blood levels, potentially improving effectiveness. The standard regimen typically involves 500mg twice daily for three to five days. Some patients find the reduced dosing frequency more manageable, particularly during the initial stages of an outbreak.
Topical Treatment Considerations
Aciclovir 5% cream provides localised treatment applied directly to affected areas. While convenient for mild outbreaks, topical treatments generally show less clinical effectiveness compared to oral formulations. The cream should typically be applied five times daily for up to 10 days, beginning at the first sign of symptoms. This option may suit patients who prefer avoiding systemic medication or experience minimal, localised symptoms.
Treatment Timing and Effectiveness
The effectiveness of any cold sore treatment depends significantly on timing. Starting aciclovir tablets during the prodromal phase - when tingling, burning, or itching sensations first occur - may provide the best outcomes. Once blisters have fully formed, antiviral treatments may have limited impact on the current outbreak but can still help prevent secondary bacterial infections and reduce viral shedding.
Choosing Between Available Options
Selection between different treatments often depends on individual factors including outbreak frequency, symptom severity, and lifestyle considerations. Patients experiencing frequent recurrences may benefit from discussing suppressive therapy with their healthcare provider. Those with infrequent, mild outbreaks might find topical treatments sufficient, while individuals with severe or frequent episodes may achieve better results with oral antivirals like aciclovir or valaciclovir tablets.
